Sumitomo Chemical India Ltd. Announces Audited Financial Results for FY 2025-26

Sumitomo Chemical India Ltd. has released its audited standalone and consolidated financial results for the fiscal year ended March 31, 2026. The company reported significant revenue and profit figures, reflecting its performance across the reporting periods. The results detail various financial metrics including profit before and after tax, comprehensive income, and earnings per share, providing a comprehensive overview of the company’s financial health for the fiscal year.

Sumitomo Chemical India Ltd. Reports FY2026 Financials

Sumitomo Chemical India Ltd. has announced its audited financial results for the fiscal year ended March 31, 2026. The company has submitted both standalone and consolidated financial statements, offering a dual perspective on its financial performance. These results cover the fourth quarter and the full fiscal year, providing a detailed look at the company’s financial standing.

Standalone Financial Performance

For the standalone results, the company reported a Total Income of ₹7,034.26 million for the quarter ended March 31, 2026, and ₹33,318.26 million for the year ended March 31, 2026. The Profit for the year (after tax) stood at ₹1,106.10 million for the quarter and ₹5,431.39 million for the full year. Total comprehensive income for the year was ₹1,103.98 million for the quarter and ₹5,474.66 million for the year.

Consolidated Financial Performance

On a consolidated basis, Sumitomo Chemical India Ltd. reported a Total Income of ₹7,159.16 million for the quarter ended March 31, 2026, and ₹33,850.36 million for the full year. The Profit for the year (after tax) was ₹1,113.16 million for the quarter and ₹5,429.75 million for the year. The total comprehensive income for the year was ₹1,116.34 million for the quarter and ₹5,485.99 million for the full year.

Key Financial Highlights

  • Standalone Profit Before Tax (after exceptional items) for the year ended March 31, 2026, was ₹7,266.49 million.
  • Consolidated Profit Before Tax (after exceptional items) for the year ended March 31, 2026, was ₹7,275.63 million.
  • Basic and Diluted Earnings Per Share (EPS) for the standalone results were ₹2.22 for the quarter and ₹10.88 for the year.
  • Basic and Diluted Earnings Per Share (EPS) for the consolidated results were ₹2.23 for the quarter and ₹10.88 for the year.

Other Disclosures

The company noted that its business is seasonal and performance is dependent on monsoon and other climatic conditions. It also provided updates on the impact of the Government’s new Labour Codes and the ongoing legal proceedings related to Glyphosate. A dividend of 13% was declared for FY 2025-26.

Related Party Transactions

The document also includes Annexure II, detailing related party transactions. These transactions involved entities such as Sumitomo Chemical Company, Holding Company, and various subsidiaries, covering purchases and reimbursements of expenses, with values ranging from ₹0.08 million to ₹3,821.76 million.

Source: BSE

Previous Article

Sun Pharmaceutical Industries Limited Announces 34th AGM and Final Dividend for FY 2025-26

Next Article

NLC India Limited Signs MOU with CSIR-CECRI for Critical Mineral Collaboration